A Study of Merestinib (LY2801653) in Healthy Participants

NCT02779738 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Merestinib

Sponsor

Eli Lilly and Company